Option delistings effective August 18th include Q32 Bio Inc (QTTB), Hyperdynamics Corp (HYPD), Bionano Genomics (BNGO), Allurion Technologies Inc (ALUR), Moxian (BVI) Inc (ABTS), Spi Energy Co Ltd (SPIEF), TVARDI THERAPEUTICS INC (TVRD), and ZK International Group Ltd (ZKIN).
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QTTB:
- Q32 Bio Inc. Advances Alopecia Areata Treatment with Phase 2a Trial of Bempikibart
- Q32 Bio Inc. Reports Continued Losses Amid Development Efforts
- Q32 Bio Appoints New Interim Chief Medical Officer
- Q32 Bio chief medical officer Jason Campagna to depart
- Oxford Biomedica completes acquisition of remaining stake in U.S. subsidiary